IL17A and precursor B-cell acute lymphoblastic leukemia: Furthermore, the BCR-ABL signaling pathway was indeed activated in the IL-17A high subgroup and IL-17RA high subgroups of Ph+ B-ALL patients (Supplementary Fig. 4f, g).